Average Co-Inventor Count = 10.40
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (26 from 3,923 patents)
2. Array Biopharma Inc. (8 from 329 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (6 from 245 patents)
4. Irm LLC (3 from 151 patents)
5. Chiron Corporation (2 from 656 patents)
6. Korea Research Institute of Chemical Technology (2 from 623 patents)
7. Katholieke Universiteit Leuven (2 from 345 patents)
42 patents:
1. 12286423 - Antiviral 1,3-di-oxo-indene compounds
2. 12083092 - Antiviral 1,3-di-oxo-indene compounds
3. 12071441 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
4. 11912715 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
5. RE49556 - Compounds and compositions as protein kinase inhibitors
6. 11629149 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
7. 11098051 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
8. 10660888 - Aminoheteroaryl benzamides as kinase inhibitors
9. 10576080 - Compounds and compositions as protein kinase inhibitors
10. 10568884 - Compounds and compositions as protein kinase inhibitors
11. 10188649 - Aminoheteroaryl benzamides as kinase inhibitors
12. 10160764 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
13. 10005761 - Compounds and compositions as protein kinase inhibitors
14. 9850229 - Compounds and compositions as protein kinase inhibitors
15. 9850230 - Compounds and compositions as protein kinase inhibitors